A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma

NCT00920556 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
24
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated.24 subjects enrolled;provided adequate data for decision making.

Conditions

Interventions

Sponsor

Sirtris, a GSK Company

Collaborators